Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer treatment Read more
Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy challenges Read more
Bolstering India’s healthcare innovation in cancer, rare diseases: How Budget 2025 can make a difference? Read more
TechInvention partners with Ethiopia’s Ministry of Health to advance vaccine manufacturing in Africa Read more
